CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
-9.14%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.68B
AUM Growth
+$1.68B
(-32%)
Cap. Flow
-$192M
Cap. Flow
% of AUM
-11.44%
Top 10 Holdings %
Top 10 Hldgs %
50.05%
Holding
96
New
8
Increased
9
Reduced
34
Closed
18
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
$31.9M |
| 2 |
Ventyx Biosciences
VTYX
|
$15.1M |
| 3 |
VERV
Verve Therapeutics
VERV
|
$14.7M |
| 4 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$14.6M |
| 5 |
Adicet Bio
ACET
|
$13.1M |
Top Sells
| 1 |
Atea Pharmaceuticals
AVIR
|
$29M |
| 2 |
AGEN
Agenus
AGEN
|
$25.2M |
| 3 |
Revolution Medicines
RVMD
|
$17.9M |
| 4 |
Ascendis Pharma
ASND
|
$16.1M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$15.4M |
Sector Composition
| 1 | Healthcare | 99.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pliant Therapeutics
PLRX
$105M
| $6.51M | 0.39% |
482,413
| – | – |
|
52
Aligos Therapeutics
ALGS
$75.1M
| $6.19M | 0.37% |
521,257
-145,910
| -22% | -$1.73M |
|
53
Viridian Therapeutics
VRDN
$1.59B
| $5.93M | 0.35% |
300,000
-42,562
| -12% | -$841K |
|
54
Eledon Pharmaceuticals
ELDN
$155M
| $5.76M | 0.34% |
1,305,095
| – | – |
|
55
Y-mAbs Therapeutics
YMAB
$390M
| $4.86M | 0.29% |
300,000
-200,000
| -40% | -$3.24M |
|
56
Cabaletta Bio
CABA
$144M
| $4.38M | 0.26% |
1,154,424
-457,199
| -28% | -$1.73M |
|
57
MoonLake Immunotherapeutics
MLTX
$3.78B
| $4.25M | 0.25% |
430,000
| – | – |
|
|
HARP
58
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $4.08M | 0.24% |
540,600
| – | – |
|
59
Celldex Therapeutics
CLDX
$1.57B
| $3.86M | 0.23% |
+100,000
| New | +$3.86M |
|
|
RCOR
60
DELISTED
Renovacor, Inc.
RCOR
| $3.85M | 0.23% |
500,000
| – | – |
|
61
MeiraGTx Holdings
MGTX
$590M
| $3.56M | 0.21% |
+150,000
| New | +$3.56M |
|
62
AnaptysBio
ANAB
$630M
| $3.48M | 0.21% |
100,000
-285,081
| -74% | -$9.91M |
|
|
AKUS
63
DELISTED
Akouos, Inc. Common Stock
AKUS
| $3.35M | 0.2% |
394,500
| – | – |
|
64
Merus
MRUS
$5.04B
| $3.18M | 0.19% |
100,000
-150,000
| -60% | -$4.77M |
|
65
Galecto
GLTO
$3.93M
| $3.09M | 0.18% |
1,020,238
-130,492
| -11% | -$395K |
|
66
Astria Therapeutics
ATXS
$394M
| $2.98M | 0.18% |
552,903
| – | – |
|
67
Precision BioSciences
DTIL
$59.5M
| $2.56M | 0.15% |
346,524
| – | – |
|
|
LENZ
68
LENZ Therapeutics
LENZ
$1.12B
| $2.53M | 0.15% |
203,153
| – | – |
|
69
Gossamer Bio
GOSS
$587M
| $2.24M | 0.13% |
198,382
| – | – |
|
|
AUTL
70
Autolus Therapeutics
AUTL
$383M
| $2.04M | 0.12% |
392,167
| – | – |
|
71
uniQure
QURE
$954M
| $1.04M | 0.06% |
50,000
-189,548
| -79% | -$3.93M |
|
|
CNTB
72
Connect Biopharma
CNTB
$111M
| $1.03M | 0.06% |
200,000
-300,000
| -60% | -$1.55M |
|
|
SONX
73
DELISTED
Sonendo, Inc.
SONX
| $859K | 0.05% |
+149,200
| New | +$859K |
|
|
BCEL
74
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $829K | 0.05% |
273,500
| – | – |
|
|
ORTX
75
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $339K | 0.02% |
256,649
| – | – |
|